There is no FDA guidance on the use of Bisacodyl in patients with hepatic impairment.įemales of Reproductive Potential and Males There is no FDA guidance on the use of Bisacodyl in patients with renal impairment. There is no FDA guidance on the use of Bisacodyl with respect to specific racial populations. There is no FDA guidance on the use of Bisacodyl with respect to specific gender populations. There is no FDA guidance on the use of Bisacodyl with respect to geriatric patients. There is no FDA guidance on the use of Bisacodyl with respect to pediatric patients. There is no FDA guidance on use of Bisacodyl during labor and delivery. There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Bisacodyl in women who are pregnant.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |